ArticleFrontiers in public health2026
Trend of measles outbreak in Galmudug, Somalia: a retrospective study from 2023 to 2024.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Measles remains a significant public health concern in Somalia, with recurrent outbreaks despite the availability of vaccines. This retrospective study aimed to examine the trends of measles outbreaks in Galmudug State, Somalia, between April 2023 and December 2024. Methods: A retrospective cross-sectional study was conducted using surveillance data from the Galmudug State Public Health Laboratory. All suspected and laboratory-confirmed measles cases reported between April 2023, and December 2024 were included. Data was analyzed using Microsoft Excel and SPSS version 26, focusing on demographic characteristics, temporal distribution, and IgM confirmation rates. Descriptive statistics, the chi-square (χ Results: A total of 1,705 suspected measles cases were reported during the study period, of which 104 (6.0%) were laboratory confirmed. The incidence rate increased from 4.9 per 10,000 population in 2023 to 8.1 per 10,000 in 2024. The highest burden occurred among children aged 5-9 years (30%), followed by those aged 0-4 years (25.9%). Dusamareb District accounted for 95.8% of reported cases. No significant gender difference was observed ( Conclusion: The resurgence of measles in Galmudug indicates persistent immunity gaps and inadequate vaccination coverage, particularly among young children. Strengthening routine immunization, ensuring equitable access to vaccines, and enhancing surveillance and outbreak response mechanisms are critical to achieving measles elimination targets in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.